IBDEI250 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34134,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,34134,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,34134,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,34135,0)
 ;;=F03.90^^134^1724^18
 ;;^UTILITY(U,$J,358.3,34135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34135,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,34135,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,34135,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,34136,0)
 ;;=G31.84^^134^1724^23
 ;;^UTILITY(U,$J,358.3,34136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34136,1,3,0)
 ;;=3^Mild Cognitive Impairment,So Stated
 ;;^UTILITY(U,$J,358.3,34136,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,34136,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,34137,0)
 ;;=F02.81^^134^1724^14
 ;;^UTILITY(U,$J,358.3,34137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34137,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/ Behav Dist
 ;;^UTILITY(U,$J,358.3,34137,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,34137,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,34138,0)
 ;;=F02.80^^134^1724^15
 ;;^UTILITY(U,$J,358.3,34138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34138,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/o Behav Dist
 ;;^UTILITY(U,$J,358.3,34138,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,34138,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,34139,0)
 ;;=A81.01^^134^1724^9
 ;;^UTILITY(U,$J,358.3,34139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34139,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,34139,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,34139,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,34140,0)
 ;;=F05.^^134^1724^13
 ;;^UTILITY(U,$J,358.3,34140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34140,1,3,0)
 ;;=3^Delirium d/t Physiological Cond
 ;;^UTILITY(U,$J,358.3,34140,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,34140,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,34141,0)
 ;;=R41.0^^134^1724^19
 ;;^UTILITY(U,$J,358.3,34141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34141,1,3,0)
 ;;=3^Disorientation,Unspec
 ;;^UTILITY(U,$J,358.3,34141,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,34141,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,34142,0)
 ;;=G31.09^^134^1724^20
 ;;^UTILITY(U,$J,358.3,34142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34142,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,34142,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,34142,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,34143,0)
 ;;=G90.3^^134^1724^24
 ;;^UTILITY(U,$J,358.3,34143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34143,1,3,0)
 ;;=3^Multi-System Degeneration of Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,34143,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,34143,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,34144,0)
 ;;=A81.9^^134^1724^28
 ;;^UTILITY(U,$J,358.3,34144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34144,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,34144,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,34144,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,34145,0)
 ;;=S06.2X9S^^134^1724^31
 ;;^UTILITY(U,$J,358.3,34145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34145,1,3,0)
 ;;=3^TBI,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,34145,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,34145,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,34146,0)
 ;;=R41.9^^134^1724^25
